AuthorisedPhase I and Phase II (Integrated)- OtherInterventional

Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response.

This study is investigating new ways to tell early on if breast cancer treatment is effective. Researchers are using a special type of PET (Positron Emission Tomography) scan, designed specifically for the breast, to look closely at breast tumours. These scans use a small amount of a 'tracer' substance that helps show how active the cancer cells are. By measuring changes in how these cells grow and change, the study hopes to find an earlier and more accurate way to know if a treatment is working. This could help doctors make quicker decisions about patient care.

At a glance

Status

Authorised

Phase

Phase I and Phase II (Integrated)- Other

Sponsor

Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela

Enrolment target

100

Start

15 Nov 2024

Breast cancer

What is this study about?

This study is exploring improved methods to quickly determine whether a treatment for breast cancer is successful. Currently, it can take some time to know if a new treatment is making a difference. This study aims to find a faster way to get this information.

The researchers are using a special type of scan called a PET scan, which is specifically adapted to get a very detailed look at breast tumours. During this scan, a harmless, mildly radioactive substance called a 'radiotracer' is given. This tracer highlights how quickly cells within the tumour are growing. By looking at these growth patterns, the doctors hope to understand the 'personality' of the tumour better and see early on if it's responding to treatment, even before visible changes appear on regular scans.

Finding out sooner if a treatment is working is really important. If a treatment isn't effective, doctors could switch to a different one earlier, potentially saving valuable time and improving the chances of success for patients.

Key takeaways

This study aims to find better ways to check if breast cancer treatment is working early on.
It uses special PET scans of the breast to look at how cancer cells grow.
Early information on treatment effectiveness can help doctors make quicker decisions.
The study is open to women aged 18 and older.
Participation would likely involve multiple scans and health checks.
It contributes to understanding breast cancer better for future patients.

Who may be eligible?

This study is for women aged 18 and over. While the detailed criteria aren't provided, generally, studies like this look for people with breast cancer who are about to start a new treatment or are already undergoing treatment.

It's important to remember that even if you meet the basic age and sex requirements, there might be other medical conditions, past treatments, or medication you are taking that would mean this study isn't suitable for you. This is to ensure your safety and that the study can collect clear results.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Are you female?
Do you have a diagnosis of breast cancer?
Are you considering or undergoing breast cancer treatment?

Answer every question to see your result.

What does participation involve?

The information provided does not give specific details about what taking part in this study would involve. However, typically for a study using dedicated PET scans, you would likely have a series of these special scans before, during, and possibly after your breast cancer treatment. This would involve visiting the study clinic or hospital for these scanning appointments.

Beyond the scans, you would probably have regular health check-ups and discussions with the study team to monitor your well-being. The total duration of your participation would depend on your treatment plan and how long the researchers need to track your response.

Potential risks and benefits

Taking part in a study like this could offer potential benefits, such as having very detailed scans of your breast cancer and contributing to medical knowledge that could help future patients. Potential risks might include discomfort from the scanning procedures, and exposure to a very small amount of radiation from the PET tracers, similar to other medical scans. You will always have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

—
Unverified
Spain

Common questions

What is a dedicated breast PET scan?

It's a special type of scan, like an X-ray, but it gives doctors a detailed look at how active cells are inside your breast, using a small, safe amount of a tracer substance.

What does 'proliferation radiotracers' mean?

These are the special substances used in the PET scan. They help highlight cells that are growing and dividing, which is how doctors can see the cancer's activity.

Why is early detection of treatment response important?

Knowing early if a treatment is working means doctors can quickly adjust your care if needed, potentially improving your chances of success and avoiding treatments that aren't effective.

Does this study involve new treatments?

The information doesn't say this specific study is testing new treatments. It's focused on finding a better way to *monitor* how existing or planned breast cancer treatments are working.

Will I get my scan results?

Generally, scan results would be shared with your healthcare team to guide your treatment, and they would discuss them with you. Always ask the study team about this.